Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: Effects related to activity and Sec contents of thioredoxin reductase

Biochemical Journal

Volumn 447, Issue 1, 2012, Pages 167-174

  Peng, Xiaoxiao ^a   Xu, Jianqiang ^a   Arnér, Elias S J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cis diamminedichloroplatinum(II) cisplatin (cDDP); Selenium; Selenium compromised thioredoxin reductase derived apoptotic protein (SecTRAP); Selenocysteine (Sec); Thiophosphate (SPO3); Thioredoxin reductase 1 (TrxR1)

Indexed keywords

CISPLATIN; GLUTATHIONE; PHOSPHOROTHIOIC ACID; SELENITE; THIOREDOXIN REDUCTASE 1;

ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPLETION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CISPLATIN; CYSTEINE; DINITROCHLOROBENZENE; GLUTATHIONE; HCT116 CELLS; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHATES; RATS; SELENOCYSTEINE; SODIUM SELENITE; THIOREDOXIN REDUCTASE 1;

EID: 84866353255     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120683     Document Type: Article

References (38)

1. Nordberg, J. and Arnér, E. S. (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biol. Med. 31, 1287-1312
2. Arnér, E. S. and Holmgren, A. (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109
3. Nakamura, H., Nakamura, K. and Yodoi, J. (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369
4. Holmgren, A. (1985) Thioredoxin. Annu. Rev. Biochem. 54, 237-271
5. Cheng, Q., Sandalova, T., Lindqvist, Y. and Arnér, E. S. J. (2009) Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1. J. Biol. Chem. 284, 3998-4008
6. Zhong, L., Arnér, E. S. J. and Holmgren, A. (2000) Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc. Natl. Acad. Sci. U.S.A. 97, 5854-5859
7. Lee, S. R., Bar-Noy, S., Kwon, J., Levine, R. L., Stadtman, T. C. and Rhee, S. G. (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. U.S.A. 97, 2521-2526
8. Zhong, L. and Holmgren, A. (2000) Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Biol. Chem. 275, 18121-18128
9. Arnér, E. S. J. (2009) Focus on mammalian thioredoxin reductases: important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790, 495-526
10. Anestål, K. and Arnér, E. S. J. (2003) Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J. Biol. Chem. 278, 15966-15972
11. Anestål, K., Prast-Nielsen, S., Cenas, N. and Arnér, E. S. J. (2008) Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. PLoS ONE 3, e1846
12. Xu, X. M., Turanov, A. A., Carlson, B. A., Yoo, M. H., Everley, R. A., Nandakumar, R., Sorokina, I., Gygi, S. P., Gladyshev, V. N. and Hatfield, D. L. (2010) Targeted insertion of cysteine by decoding UGA codons with mammalian selenocysteine machinery. Proc. Natl. Acad. Sci. U.S.A. 107, 21430-21434
13. Lu, J., Zhong, L., Lonn, M. E., Burk, R. F., Hill, K. E. and Holmgren, A. (2009) Penultimate selenocysteine residue replaced by cysteine in thioredoxin reductase from selenium-deficient rat liver. FASEB J. 23, 2394-2402
14. Jiang, L., Weston, K. M. and Conigrave, A. D. (1996) Thiophosphate induces apoptosis in human leukemia cell lines. Biochem. Biophys. Res. Commun. 219, 393-397
15. Sun, I. Y. and Allfrey, V. G. (1982) In vivo thiophosphorylation of chromosomal proteins: recovery and analysis of HeLa histones and derivative phosphopeptides. J. Biol. Chem. 257, 1347-1353
16. Cheng, Q., Antholine, W. E., Myers, J. M., Kalyanaraman, B., Arner, E. S. and Myers, C. R. (2010) The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities. J. Biol. Chem. 285, 21708-21723
17. Rengby, O., Johansson, L., Carlson, L. A., Serini, E., Vlamis-Gardikas, A., Kårsnäs, P. and Arnér, E. S. J. (2004) Assessment of production conditions for efficient use of Escherichia coli in high-yield heterologous recombinant selenoprotein synthesis. Appl. Environ. Microbiol. 70, 5159-5167
18. Eriksson, S. E., Prast-Nielsen, S., Flaberg, E., Szekely, L. and Arnér, E. S. J. (2009) High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radical Biol. Med. 47, 1661-1671
19. Gallegos, A., Berggren, M., Gasdaska, J. R. and Powis, G. (1997) Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res. 57, 4965-4970
20. c - cystine transporter explains the cancer-specific cytotoxicity of selenite. Proc. Natl. Acad. Sci. U.S.A. 106, 11400-11405
21. Nordlund, P. and Reichard, P. (2006) Ribonucleotide reductases. Annu. Rev. Biochem. 75, 681-706
22. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K. and Ichijo, H. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606
23. Cassidy, P. B., Edes, K., Nelson, C. C., Parsawar, K., Fitzpatrick, F. A. and Moos, P. J. (2006) Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 27, 2538-2549
24. Lu, J. and Holmgren, A. (2009) Selenoproteins. J. Biol. Chem. 284, 723-727
25. Watson, W. H., Heilman, J. M., Hughes, L. L. and Spielberger, J. C. (2008) Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation. Biochem. Biophys. Res. Commun. 368, 832-836
26. Mandal, P. K., Schneider, M., Kolle, P., Kuhlencordt, P., Forster, H., Beck, H., Bornkamm, G. W. and Conrad, M. (2010) Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. 70, 9505-9514
27. Rollins, M. F., van der Heide, D. M., Weisend, C. M., Kundert, J. A., Comstock, K. M., Suvorova, E. S., Capecchi, M. R., Merrill, G. F. and Schmidt, E. E. (2010) Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration. J. Cell Sci. 123, 2402-2412
28. Suvorova, E. S., Lucas, O., Weisend, C. M., Rollins, M. F., Merrill, G. F., Capecchi, M. R. and Schmidt, E. E. (2009) Cytoprotective Nrf2 pathway is induced in chronically Txnrd1-deficient hepatocytes. PLoS ONE 4, e6158
29. Suzuki, T., Kelly, V. P., Motohashi, H., Nakajima, O., Takahashi, S., Nishimura, S. and Yamamoto, M. (2008) Deletion of the selenocysteine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2. J. Biol. Chem. 283, 2021-2030
30. Kawatani, Y., Suzuki, T., Shimizu, R., Kelly, V. P. and Yamamoto, M. (2011) Nrf2 and selenoproteins are essential for maintaining oxidative homeostasis in erythrocytes and protecting against hemolytic anemia. Blood 117, 986-996
31. Stenvall, J., Fierro-Gonzalez, J. C., Swoboda, P., Saamarthy, K., Cheng, Q., Cacho-Valadez, B., Arnér, E. S. J., Persson, O. P., Miranda-Vizuete, A. and Tuck, S. (2011) Selenoprotein TRXR-1 and GSR-1 are essential for removal of old cuticle during molting in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 108, 1064-1069
32. Kim, S. J., Kim, H. G., Lim, H. W., Park, E. H. and Lim, C. J. (2005) Up-regulation of glutathione biosynthesis in NIH3T3 cells transformed with the ETV6 -NTRK3 gene fusion. Mol. Cells 19, 131-136
33. Prigge, J. R., Eriksson, S., Iverson, S. V., Meade, T. A., Capecchi, M. R., Arnér, E. S. J. and Schmidt, E. E. (2012) Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of Txnrd1. Free Radical Biol. Med. 52, 803-810
34. Nordberg, J., Zhong, L., Holmgren, A. and Arnér, E. S. J. (1998) Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J. Biol. Chem. 273, 10835-10842
35. Habig, W. H., Pabst, M. J. and Jakoby, W. B. (1974) Glutathione S-transferases: the first enzymatic step in mercaptopuric acid formation. J. Biol. Chem. 249, 7130-7139
36. Urig, S. and Becker, K. (2006) On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin. Cancer Biol. 16, 452-465
37. Arnér, E. S. J. and Holmgren, A. (2006) The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420-426
38. Gromer, S., Urig, S. and Becker, K. (2004) The thioredoxin system: from science to clinic. Med. Res. Rev. 24, 40-89